Piramal Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 6, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	300,030	170,528	81,683	-	-
Market Cap Growth	88.96%	108.77%	-	-	-
Enterprise Value	342,117	209,922	130,128	-	-
Last Close Price	226.31	128.81	66.80	-	-
PE Ratio	-	926.01	-42.64	-	-
PS Ratio	3.53	2.09	1.15	-	-
PB Ratio	3.78	2.16	1.21	-	-
P/FCF Ratio	-	58.30	-16.99	-	-
P/OCF Ratio	-	16.98	16.88	-	-
EV/Sales Ratio	4.09	2.57	1.84	-	-
EV/EBITDA Ratio	25.91	18.43	22.58	-	-
EV/EBIT Ratio	58.10	45.62	-291.44	-	-
EV/FCF Ratio	-	71.77	-27.06	-	-
Debt / Equity Ratio	0.60	0.60	0.83	0.62	0.54
Debt / EBITDA Ratio	3.76	4.00	9.21	3.63	2.30
Debt / FCF Ratio	-	16.10	-11.72	-33.54	-710.89
Asset Turnover	-	0.55	0.52	0.57	-
Inventory Turnover	-	1.69	1.94	1.87	-
Quick Ratio	-	0.61	0.64	0.69	0.82
Current Ratio	-	1.25	1.26	1.34	1.47
Return on Equity (ROE)	-	0.24%	-2.77%	6.11%	-
Return on Assets (ROA)	-	1.93%	-0.20%	2.96%	-
Return on Capital (ROIC)	2.60%	2.30%	-0.24%	3.60%	-
Earnings Yield	0.09%	0.10%	-2.28%	-	-
FCF Yield	1.72%	-5.89%	-	-
Dividend Yield	0.05%	0.09%	-	-	-
Payout Ratio	0.00%	-	-	13.30%	-
Buyback Yield / Dilution	-10.02%	-7.85%	-0.95%	-87.83%	-
Total Shareholder Return	-9.97%	-7.76%	-0.95%	-87.83%	-

Source: S&P Capital IQ. Standard template. Financial Sources.